University of Colorado in the pharma news with heavy funding

Posted on 27 August 2014

Tags: , , ,

Pharma news: University of Colorado faculty researchers attracted $861.04 million in research awards in the 2013-14 fiscal year, based on preliminary figures.

That total investment in exploration taking place at CU campuses represents a stunning jump of 11.7 percent over the previous year’s total, $770.53 million, which came at an especially competitive time for research institutions given tightening federal budgets.

This year’s figure is bested by just one other in CU history, FY2010, when one-time federal stimulus dollars helped fuel research awards of $884.1 million.

Three of the four CU campuses were beneficiaries of research award increases this year, with the University of Colorado Boulder seeing the greatest dollar increase over the previous year – $60.2 million.

Following are the totals in sponsored research funding at CU campuses, along with examples of the life-changing work such awards enable:

• University of Colorado Boulder, $412.10 million, including a $5.5 million grant from the National Institutes of Health for research by Leslie Leinwand, Ph.D., into cardiac myosin genes.

She studies genetic mutations that cause severe genetic heart disease, including hypertrophic cardiomyopathy – the leading cause of sudden death in young athletes.

• University of Colorado Colorado Springs, $9.40 million, including a two-year, $325,000 grant from the U.S. Department of Health and Human Services, Health Resources and Services Administration.

The Department of Psychology will use the Graduate Psychology Education grant to prepare doctoral students in the clinical psychology program to deliver mental health services to older adults within integrated medical settings.

• University of Colorado Denver, $13.57 million, including a grant of just under $1 million that will boost the number of minority Ph.D. candidates in science, technology, engineering and mathematics – the STEM disciplines – at the University of Colorado Denver

• University of Colorado Anschutz Medical Campus, $425.97 million, including a $2.5 million award from the American Heart/Stroke Association and the Bugher Foundation.

It forms the basis of the new University of Colorado Denver | Anschutz Medical Campus ASA/Bugher Foundation Stroke Collaborative Research Center of Excellence.

Richard J. Traystman, Ph.D., and his research group are looking for a better understanding of and innovative treatments for stroke in children, who often are left with devastating lifelong consequences.

For further deal information visit Current Agreements (subscription required)


Report: Cardiovascular Partnering Terms and Agreements

Browse: Complete Current Partnering report catalog

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply